Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

June 30, 2015 9:21 AM ET

Healthcare Equipment and Supplies

Company Overview of Gamma Medica, Inc.

Company Overview

Gamma Medica, Inc., a medical device company, develops, manufactures, and markets digital molecular imaging technologies for the detection of breast cancer. The company offers LumaGEM Molecular Breast Imaging system, a diagnostic tool for detecting early-stage cancers in dense breast tissue; and LumaGUIDE biopsy accessory, a lesion localization accessory used in conjunction with the LumaGEM molecular breast imaging system. It also provides training, and service and maintenance contracts for its molecular breast imaging systems. Gamma Medica, Inc. has a strategic partnership with Volpara Solutions. The company was formerly known as Gamma Medica-Ideas, Inc. and changed its name to Gamma Medica...

12 Manor Parkway

Unit 3

Salem, NH 03079

United States

Founded in 1997





Key Executives for Gamma Medica, Inc.

Chief Executive Officer and President
Age: 53
Co-Founder and Vice-Chairman
Co-Founder and Director
Age: 67
Vice President of Finance & Administration
General Manager of Norway Operations Industrial Division Imaging
Compensation as of Fiscal Year 2014.

Gamma Medica, Inc. Key Developments

Gamma Medica Announces Management Changes

Gamma Medica announced that Philip M. Croxford has been appointed as Chief Executive Officer. The company also named Scott Headland as its new Vice President of Sales. These executive changes align with Gamma Medica’s focus on commercializing its unique breast imaging technology for improved cancer detection in the 40% of women with dense breast tissue. The company's former CEO, Jim Calandra, has left the company to pursue other business opportunities. Croxford is a seasoned leader with extensive expertise in driving growth and building strong global brands in a wide range of medical modalities. With over 25 years of experience in the bio-surgical and medical device business, he has previously held CEO and President positions at LifeCell Corporation, Getinge AB, Draeger Medical and Johnson & Johnson ETHICON. At Gamma Medica, Croxford will be responsible for driving the successful commercialization of the company’s LumaGEM MBI system. As Vice President of Sales, Headland will lead Gamma Medica’s newly expanded sales team and focus on sales and marketing opportunities for the LumaGEM MBI system. He has over 25 years of experience in capital medical imaging sales and was most recently National Sales Director for the Interventional X-ray Division at Toshiba America Medical Systems.

Gamma Medica Creates Strategic Advisory Board Chaired by Robert Cascella

Gamma Medica announced that it has formed a strategic advisory board comprised of distinguished clinicians and thought leaders with expertise in women's health technologies and diagnostic imaging. Robert Cascella will chair the strategic advisory board. The board will provide strategic and operational counsel as Gamma Medica continues the development and commercialization of its LumaGEM(R) Molecular Breast Imaging system. Robert Cascella has more than 30 years of senior management, operational and finance experience. From 2009 to 2013, he was president and chief executive officer of Hologic. Dr. R. James Brenner is board certified in both diagnostic radiology and nuclear radiology and is director of breast imaging for Bay Imaging Consultants, Inc., which provides services throughout the East Bay of Northern California with a group of more than 80 radiologists. He is also clinical professor of radiology at the University of California, San Francisco. Dr. Sanjiv Sam Gambhir is internationally recognized for his pioneering work in molecular imaging, including positron emission tomography (PET). He is currently the chairman of the Stanford School of Medicine's Department of Radiology, the director of the university's Molecular Imaging Program, and also head of its Canary Center for Cancer Early Detection. Dr. Andrew Maidment is a board-certified medical physicist and researcher at the University of Pennsylvania, where he serves as chief of physics for radiology in the University Health System and as an associate professor of radiology. He is also co-director of the HHMI-NIBIB Interfaces Graduate Program in Biomedical Imaging and Information Sciences at the university. Dr. Jeffrey Mendel is a radiologist with more than 30 years experience with breast imaging. Dr. Mendel is board certified in both nuclear medicine and diagnostic radiology. Dr. Margo Moskos is a senior staff breast radiologist at Massachusetts General Hospital. Dr. Moskos is board certified in diagnostic radiology by the American Board of Radiology. Dr. Robin Shermis is a senior managing partner in a 30-person radiology practice in Northwest Ohio (Toledo Radiological Associates, Inc.).

Similar Private Companies By Industry

Company Name Region
Image Medical Corporation United States
Corvita Corporation United States
Reverse Medical Corporation United States
CuraSeal, Inc. United States
CertiChem, Inc. United States

Recent Private Companies Transactions

Private Placement
September 30, 2014

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Gamma Medica, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at